Mesa Laboratories, Inc.

Mesa Laboratories, Inc.

MLAB - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$715.21M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mesa Laboratories, Inc.Mesa Laboratories, Inc.148.60.5%3%2.80.6
$110.00

Target Price by Analysts

9.8% downsideMesa Laboratories Target Price DetailsTarget Price
$147.25

Current Fair Value

20.7% upside

Undervalued by 20.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$715.21 Million
Enterprise Value$800.39 Million
Annual dividend$0.64
Dividend yield0.50%
Earnings per Share$1.22
Beta1.05
Outstanding Shares5,657,000

Return

Return on Equity2.54%ROE
Return on Assets1.14%
Return on Invested Capital6.00%

Valuation & Multiples

P/E Ratio148.62P/E Ratio
PEG-368.59PEG
Price to Sales2.77Price to Sales
Price to Book Ratio3.7Price to Book Ratio
Enterprise Value to Revenue3.21
Enterprise Value to EBIT36.11
Enterprise Value to Net Income166
Total Debt to Enterprise0.14
Debt to Equity0.61Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 10, 2026
EPS Estimate
$2.63
Consensus analyst estimate
Revenue Estimate
$60.87 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.29
Consensus analyst estimate
Revenue Estimate
$62.20 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.41%▼ 82.51%
Total Invested$54.46M▼ 89.24%
Investors Holding31▼ 130.00%

About Mesa Laboratories, Inc.

CEO: Gary Owens

Mesa Laboratories Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in Mesa Laboratories. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider purchases and 7 open-market insider sales for Mesa Laboratories in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.